Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoplasmic Reticulum | 31 | 2017 | 112 | 4.750 |
Why?
|
| Calcium | 37 | 2017 | 189 | 4.690 |
Why?
|
| Myocytes, Cardiac | 20 | 2017 | 33 | 4.060 |
Why?
|
| Calcium Signaling | 14 | 2017 | 61 | 2.190 |
Why?
|
| Myocardium | 18 | 2016 | 46 | 1.880 |
Why?
|
| Myocardial Contraction | 12 | 2016 | 19 | 1.850 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 12 | 2016 | 70 | 1.600 |
Why?
|
| Animals | 42 | 2017 | 748 | 1.470 |
Why?
|
| Heart Failure | 8 | 2010 | 15 | 1.370 |
Why?
|
| Isoproterenol | 7 | 2014 | 10 | 0.990 |
Why?
|
| Heart Ventricles | 12 | 2016 | 20 | 0.900 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 6 | 2017 | 9 | 0.880 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2013 | 15 | 0.860 |
Why?
|
| Adrenergic beta-Agonists | 4 | 2013 | 7 | 0.800 |
Why?
|
| Rabbits | 15 | 2017 | 52 | 0.760 |
Why?
|
| Calcium-Transporting ATPases | 10 | 2005 | 13 | 0.730 |
Why?
|
| Ion Channel Gating | 5 | 2016 | 52 | 0.690 |
Why?
|
| Action Potentials | 4 | 2016 | 33 | 0.670 |
Why?
|
| Heart | 5 | 2002 | 14 | 0.540 |
Why?
|
| Cells, Cultured | 12 | 2016 | 88 | 0.540 |
Why?
|
| Diastole | 7 | 2010 | 13 | 0.430 |
Why?
|
| Mice | 9 | 2017 | 215 | 0.430 |
Why?
|
| Adrenergic Agents | 1 | 2014 | 1 | 0.430 |
Why?
|
| Nitric Oxide | 1 | 2014 | 10 | 0.430 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2017 | 4 | 0.390 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2010 | 15 | 0.370 |
Why?
|
| Calcium Channels | 6 | 2011 | 72 | 0.370 |
Why?
|
| Calcium-Binding Proteins | 5 | 2011 | 12 | 0.350 |
Why?
|
| Models, Cardiovascular | 4 | 2016 | 5 | 0.340 |
Why?
|
| Patch-Clamp Techniques | 6 | 2016 | 43 | 0.330 |
Why?
|
| Models, Biological | 5 | 2017 | 99 | 0.330 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 13 | 0.330 |
Why?
|
| Ventricular Function | 3 | 2007 | 4 | 0.330 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2007 | 10 | 0.320 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 1 | 0.320 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2009 | 1 | 0.320 |
Why?
|
| Dantrolene | 1 | 2009 | 1 | 0.310 |
Why?
|
| Muscle Relaxants, Central | 1 | 2009 | 1 | 0.310 |
Why?
|
| Kinetics | 9 | 2016 | 59 | 0.290 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 26 | 0.280 |
Why?
|
| Cytosol | 7 | 2010 | 22 | 0.280 |
Why?
|
| Ventricular Premature Complexes | 1 | 2007 | 1 | 0.270 |
Why?
|
| Signal Transduction | 3 | 2017 | 73 | 0.270 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 4 | 0.270 |
Why?
|
| Calsequestrin | 1 | 2007 | 20 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 5 | 0.260 |
Why?
|
| Humans | 7 | 2016 | 1907 | 0.260 |
Why?
|
| Membrane Potentials | 4 | 2016 | 88 | 0.240 |
Why?
|
| Microscopy, Confocal | 4 | 2011 | 25 | 0.220 |
Why?
|
| Phosphorylation | 5 | 2014 | 23 | 0.220 |
Why?
|
| Sarcolemma | 2 | 1994 | 3 | 0.220 |
Why?
|
| Mice, Knockout | 3 | 2014 | 40 | 0.220 |
Why?
|
| Sodium | 2 | 2016 | 14 | 0.210 |
Why?
|
| Heart Rate | 2 | 2016 | 13 | 0.200 |
Why?
|
| Sulfonamides | 4 | 2011 | 9 | 0.180 |
Why?
|
| Rats | 9 | 2011 | 159 | 0.170 |
Why?
|
| Peptides | 2 | 2007 | 16 | 0.170 |
Why?
|
| Muscle, Skeletal | 3 | 2006 | 66 | 0.170 |
Why?
|
| Tetracaine | 3 | 2007 | 8 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2014 | 19 | 0.160 |
Why?
|
| Caffeine | 3 | 2005 | 25 | 0.150 |
Why?
|
| Microsomes | 2 | 2000 | 9 | 0.150 |
Why?
|
| Isoquinolines | 2 | 2010 | 4 | 0.150 |
Why?
|
| Calcium Channels, L-Type | 2 | 2009 | 20 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2014 | 17 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 7 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 100 | 0.140 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 1 | 0.130 |
Why?
|
| Nitric Oxide Synthase | 1 | 2017 | 2 | 0.130 |
Why?
|
| Chlorides | 1 | 2016 | 8 | 0.130 |
Why?
|
| Potassium | 1 | 2016 | 11 | 0.130 |
Why?
|
| Magnesium | 1 | 2016 | 19 | 0.130 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2016 | 7 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 54 | 0.130 |
Why?
|
| Computer Simulation | 3 | 2005 | 31 | 0.120 |
Why?
|
| Sodium-Calcium Exchanger | 4 | 2001 | 5 | 0.120 |
Why?
|
| Thermodynamics | 3 | 2016 | 16 | 0.110 |
Why?
|
| Phospholipids | 1 | 1994 | 4 | 0.110 |
Why?
|
| Receptors, Endothelin | 1 | 1994 | 3 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 1994 | 10 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 1994 | 9 | 0.110 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2014 | 1 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 5 | 0.110 |
Why?
|
| Benzylamines | 3 | 2011 | 7 | 0.100 |
Why?
|
| Ion Transport | 2 | 2004 | 12 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2013 | 11 | 0.100 |
Why?
|
| Nuclear Envelope | 1 | 2013 | 1 | 0.100 |
Why?
|
| Muscle Cells | 2 | 2010 | 4 | 0.100 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2011 | 5 | 0.090 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 67 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 2 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 3 | 0.080 |
Why?
|
| Mice, Inbred mdx | 1 | 2009 | 1 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 4 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 14 | 0.080 |
Why?
|
| Disease Progression | 1 | 2009 | 43 | 0.080 |
Why?
|
| Male | 6 | 2016 | 1055 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 6 | 1998 | 95 | 0.080 |
Why?
|
| Protein Binding | 2 | 2000 | 21 | 0.070 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2007 | 1 | 0.070 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2007 | 1 | 0.070 |
Why?
|
| Calbindin 2 | 1 | 2007 | 1 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 25 | 0.070 |
Why?
|
| Research Design | 1 | 2007 | 16 | 0.070 |
Why?
|
| Colforsin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Calmodulin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Algorithms | 2 | 2016 | 42 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2003 | 23 | 0.060 |
Why?
|
| Homeostasis | 1 | 2005 | 15 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2005 | 5 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 12 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2006 | 25 | 0.060 |
Why?
|
| Time Factors | 3 | 2000 | 143 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2004 | 35 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 19 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 22 | 0.050 |
Why?
|
| Cattle | 2 | 1994 | 14 | 0.050 |
Why?
|
| Thapsigargin | 2 | 2000 | 2 | 0.050 |
Why?
|
| Models, Theoretical | 2 | 2016 | 16 | 0.050 |
Why?
|
| Intracellular Membranes | 2 | 2000 | 9 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2000 | 10 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 2011 | 37 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1998 | 2 | 0.040 |
Why?
|
| Troponin | 1 | 2000 | 3 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 15 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 1998 | 1 | 0.040 |
Why?
|
| Calorimetry | 1 | 1997 | 1 | 0.030 |
Why?
|
| Aging | 1 | 1998 | 75 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 2 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1997 | 2 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 2 | 0.030 |
Why?
|
| Tacrolimus | 1 | 1996 | 2 | 0.030 |
Why?
|
| Ions | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cations, Monovalent | 1 | 2016 | 3 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 2 | 0.030 |
Why?
|
| Biological Transport | 3 | 2001 | 12 | 0.030 |
Why?
|
| Rana pipiens | 2 | 2006 | 45 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 1994 | 1 | 0.030 |
Why?
|
| Models, Structural | 1 | 1994 | 2 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 5 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1994 | 4 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1994 | 5 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1994 | 8 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 6 | 0.030 |
Why?
|
| Liposomes | 1 | 1994 | 7 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1994 | 1 | 0.030 |
Why?
|
| Endothelins | 1 | 1994 | 1 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1994 | 2 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 2 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1994 | 5 | 0.030 |
Why?
|
| Membranes | 1 | 1994 | 6 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 1998 | 38 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2011 | 1 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 3 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 1 | 0.020 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2011 | 1 | 0.020 |
Why?
|
| Serine | 1 | 2011 | 2 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 25 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 2 | 0.020 |
Why?
|
| Ruthenium Red | 2 | 2000 | 6 | 0.020 |
Why?
|
| Down-Regulation | 2 | 1998 | 19 | 0.020 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2005 | 1 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2005 | 2 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2005 | 8 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 9 | 0.020 |
Why?
|
| Echocardiography | 1 | 2005 | 8 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2 | 0.010 |
Why?
|
| Organelles | 1 | 2005 | 2 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 15 | 0.010 |
Why?
|
| Female | 1 | 2007 | 984 | 0.010 |
Why?
|
| Ferrets | 1 | 2001 | 3 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 2001 | 2 | 0.010 |
Why?
|
| Nickel | 1 | 2001 | 3 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 2 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 58 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 1 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 2 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1998 | 1 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1998 | 28 | 0.010 |
Why?
|
| Ruthenium Compounds | 1 | 1998 | 2 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1998 | 9 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1998 | 6 | 0.010 |
Why?
|
| Indoles | 1 | 1998 | 7 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 11 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 60 | 0.010 |
Why?
|
| Ryanodine | 1 | 1998 | 14 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 1997 | 1 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 1997 | 1 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 4 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1997 | 11 | 0.010 |
Why?
|
| Gene Expression | 1 | 1997 | 27 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1996 | 15 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 15 | 0.010 |
Why?
|
| Surgery, Plastic | 1 | 1950 | 1 | 0.010 |
Why?
|
| Anti-Allergic Agents | 1 | 1950 | 1 | 0.010 |
Why?
|
| Histamine | 1 | 1950 | 3 | 0.010 |
Why?
|
| Post-Dural Puncture Headache | 1 | 1950 | 2 | 0.010 |
Why?
|
| Headache | 1 | 1950 | 7 | 0.010 |
Why?
|
| Anesthesia | 1 | 1950 | 9 | 0.010 |
Why?
|
| Anesthesiology | 1 | 1950 | 12 | 0.010 |
Why?
|